Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
Saved in:
| Title: | Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer? |
|---|---|
| Authors: | Di Marco L; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Valerio F; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Maculan Y; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Medici B; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Spallanzani A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Dominici M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy., Ricci AD; Medical Oncology Unit, National Institute of Gastroenterology, IRCCS 'S. de Bellis' Research Hospital, Castellana Grotte, Italy., Rizzo A; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Salati M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Italy. |
| Source: | Expert opinion on biological therapy [Expert Opin Biol Ther] 2026 Mar; Vol. 26 (3), pp. 257-267. Date of Electronic Publication: 2026 Mar 11. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
